Search results
Keros Therapeutics reshuffles leadership team By Investing.com
Investing.com· 5 days agoKeros Therapeutics, Inc. (NASDAQ:KROS), a biopharmaceutical company engaged in developing treatments...
Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday? - Zentalis Pharma...
Benzinga· 4 days agoThis action follows two recent deaths due to presumed sepsis in the DENALI study. The company will...
Aptose Announces Results from Annual and Special Meeting of Shareholders
Digital Journal· 4 days agoInvestors are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the...
NewMediaWire via Yahoo Finance· 4 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...
Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with...
Benzinga· 6 days agoNurix Therapeutics, Inc. NRIX, a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory ...
Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of...
Morningstar· 5 days agoVeru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology ...
SMC Files Corporate Action with FINRA to Change its Corporate Name and Trading Symbol
Digital Journal· 2 days ago...Updates Featuring New & Exclusive AI-Powered Rendering for 3D Models and CAD Product Photography Grid Battery Metals Completes Phase 2 of its 2024 Clayton Valley Project 2024 Exploration Plan Rutherrin(R) Repurposes Non-Cancer Drugs for Cancer Therapy Honey ...
Port Tampa Bay wants to build a fourth cruise terminal - Tampa Bay Business Journal
The Business Journals· 4 days agoPort Tampa Bay, eager to expand its cruise business even further, plans to construct a fourth...
Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl
The Joplin Globe· 2 days agoORLANDO, FL / ACCESSWIRE / June 20, 2024 / Nutriband Inc.("Company") (NASDAQ:NTRB)(NASDAQ:NTRBW) provides an update on its Aversa Fentanyl...Fentanyl product development program ...
GECC Provides Updates on its Corporate Activities
Digital Journal· 5 days agoThe forward-looking statements are subject to various risks, uncertainties and other factors (collectively, the " Risks ") that could cause the Company's actual results or ...
